Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3
G. Choufani et al., Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3, LARYNGOSCOP, 111(9), 2001, pp. 1656-1662
Objectives: To investigate whether the expression of the macrophage migrati
on inhibitory factor (MIF) 1) is detectable, 2) changes in relation to recu
rrence and infection status, and 3) relates to the levels of expression of
growth regulators/differentiation markers, including galectin-1, -3, and -8
, retinoid acid receptors (RAR)]-alpha, -beta, and -gamma, binding sites fo
r sarcolectin, and invasion markers (cathepsins -B and -D, and matrix metal
loproteinases [MMP]-2, -3, and -9) in human cholesteatomas. Study Design: A
n analysis of 56 cholesteatomas resected by the same surgeon using canal wa
ll up and canal wall down surgical procedures. Methods. The immunohistochem
ical levels of expression of MIF and the proteases were quantitatively dete
rmined (using computer-assisted microscopy) on routine histologic slides by
specific antibodies, and statistically correlated to parameters of the oth
er markers determined previously in conjunction with data on apoptosis/prol
iferation. Results. AUF expression was detected. It was significantly highe
r in the epithelium (P = .002) and vessels (P = .04) of the connective tiss
ues (but not in the connective tissue itself) of recurrent as opposed to no
n-recurrent cholesteatomas. The MIF expression is significantly correlated
(P = .006) to the RAR beta expression in noninfected cholesteatomas, and to
MMP-3 (P < .01) and anti-apoptotic galectin-3 (P = .01) in infected choles
teatomas. The level of MIF expression was also correlated significantly to
MMP-9 (P = 0.003), RAR beta (P < .001), and galectin-8 (P = .003) expressio
n in the cholesteatomas regardless of their infection status. Conclusions:
MIF expression in human cholesteatomas is related to the levels of biologic
aggressiveness reflected in their recurrence status and MMP expression, an
d to the differentiation status reflected in their galactin and RAR beta ex
pressions. Together with galectin-3, it could cooperate to form an anti-apo
ptotic feedback loop.